ONTARGET should not be over interpreted

被引：6

作者：

Abutaleb, Nasrulla ^{[1
]}

机构：

[1] King Faisal Specialist Hosp & Res Ctr, Dammam, Saudi Arabia

来源：

NEPHROLOGY DIALYSIS TRANSPLANTATION | 2010年 / 25卷 / 01期

关键词：

CONVERTING-ENZYME-INHIBITOR; RANDOMIZED CONTROLLED-TRIAL; II RECEPTOR BLOCKER; DIABETIC-NEPHROPATHY; RENAL-DISEASE; PHYSICAL FUNCTION; ACE-INHIBITION; BLOOD-PRESSURE; DUAL BLOCKADE; DOUBLE-BLIND;

D O I：

10.1093/ndt/gfp633

中图分类号：

R3 [基础医学]; R4 [临床医学];

学科分类号：

1001 ; 1002 ; 100602 ;

摘要：

引用

页码：44 / 47

页数：4

共 16 条

[1] Long-term dual blockade with candesartan and lisinopril in hypertensive patients with diabetes - The CALM II study [J].

Andersen, NH ;

Eiskjer, H ;

Poulsen, PL ;

Hansen, KW ;

Knudsen, ST ;

Helleberg, K ;

Poulsen, SH ;

Mogensen, CE .

DIABETES CARE, 2005, 28 (02) :273-277

[2] Impact of achieved blood pressure on cardiovascular outcomes in the irbesartan diabetic nephropathy trial [J].

Berl, T ;

Hunsicker, LG ;

Lewis, JB ;

Pfeffer, MA ;

Porush, JG ;

Rouleau, JL ;

Drury, PL ;

Esmatjes, E ;

Hricik, D ;

Pohl, M ;

Raz, I ;

Vanhille, P ;

Wiegmann, TB ;

Wolfe, BM ;

Locatelli, F ;

Goldhaber, SZ ;

Lewis, EJ .

JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2005, 16 (07) :2170-2179

[3] Double-blind, placebo-controlled study on the effect of the aldosterone receptor antagonist spironolactone in patients who have persistent proteinuria and are on long-term angiotensin-converting enzyme inhibitor therapy, with or without an angiotensin II receptor blocker [J].

Chrysostomou, Anastasia ;

Pedagogos, Eugenia ;

MacGregor, Lachlan ;

Becker, Gavin J. .

CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2006, 1 (02) :256-262

[4] Antihypertensive medications and differences in muscle mass in older persons: The Health, Aging and Body Composition study [J].

Di Bari, M ;

van de Poll-Franse, LV ;

Onder, G ;

Kritchevsky, SB ;

Newman, A ;

Harris, TB ;

Williamson, JD ;

Marchionni, N ;

Pahor, M .

JOURNAL OF THE AMERICAN GERIATRICS SOCIETY, 2004, 52 (06) :961-966

[5] Additive effect of ACE inhibition and angiotensin II receptor blockade in type I diabetic patients with diabetic nephropathy [J].

Jacobsen, P ;

Andersen, S ;

Jensen, BR ;

Parving, HH .

JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2003, 14 (04) :992-999

[6]

Levey AS, 1996, J AM SOC NEPHROL, V7, P2616

[7]

MANN JFE, 2008, LANCET, P372

[8] RETRACTED: Combination treatment of angiotensin-II receptor blocker and angiotensin-converting-enzyme inhibitor in non-diabetic renal disease (COOPERATE): a randomised controlled trial (Retracted article. See vol. 374, pg. 1226, 2009) [J].

Nakao, N ;

Yoshimura, A ;

Morita, H ;

Takada, M ;

Kayano, T ;

Ideura, T .

LANCET, 2003, 361 (9352) :117-124

[9] Relation between use of angiotensin-converting enzyme inhibitors and muscle strength and physical function in older women: an observational study [J].

Onder, G ;

Penninx, BWJH ;

Balkrishnan, R ;

Fried, LP ;

Chaves, PHM ;

Williamson, J ;

Carter, C ;

Di Bari, M ;

Guralnik, JM ;

Pahor, M .

LANCET, 2002, 359 (9310) :926-930

[10] Performance of the modification of diet in renal disease and Cockcroft-Gault equations health and in chronic kidney in the estimation of GFR in disease [J].

Poggio, ED ;

Wang, X ;

Greene, T ;

Van Lente, F ;

Hall, PM .

JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2005, 16 (02) :459-466

← 1 2 →